Literature DB >> 7884304

Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis.

J C Renauld1, A Kermouni, A Vink, J Louahed, J Van Snick.   

Abstract

Interleukin-9 (IL-9) is a multifunctional cytokine produced by activated TH2 clones in vitro and during TH2-like T cell responses in vivo. The IL-9 receptor is a member of the hemopoietin receptor superfamily and interacts with the gamma chain of the IL-2 receptor for signal transduction. Various observations indicate that IL-9 is actively involved in mast cell responses by inducing the proliferation and differentiation of these cells. The role of IL-9 in T cell responses is less clear. Although freshly isolated normal T cells do not respond to IL-9, this cytokine induces the proliferation of murine T cell lymphomas in vitro and in vivo overexpression of IL-9 results in the development of thymic lymphomas. In the human, the existence of an IL-9-mediated autocrine loop has been suggested for some malignancies such as Hodgkin's disease. Other potential biological targets for IL-9 include B lymphocytes, hematopoietic progenitors, and immature neuronal cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884304     DOI: 10.1002/jlb.57.3.353

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  26 in total

1.  Age-related changes in dermal mast cell prevalence in BALB/c mice: functional importance and correlation with dermal mast cell expression of Kit.

Authors:  P H Hart; M A Grimbaldeston; E K Hosszu; G J Swift; F P Noonan; J J Finlay-Jones
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  Expression of interleukin-9 leads to Th2 cytokine-dominated responses and fatal enteropathy in mice with chronic Schistosoma mansoni infections.

Authors:  P G Fallon; P Smith; E J Richardson; F J Jones; H C Faulkner; J Van Snick; J C Renauld; R K Grencis; D W Dunne
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation.

Authors:  Arijita Jash; Anupama Sahoo; Gi-Cheon Kim; Chang-Suk Chae; Ji-Sun Hwang; Jung-Eun Kim; Sin-Hyeog Im
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

5.  Interleukin 9: a candidate gene for asthma.

Authors:  N C Nicolaides; K J Holroyd; S L Ewart; S M Eleff; M B Kiser; C R Dragwa; C D Sullivan; L Grasso; L Y Zhang; C J Messler; T Zhou; S R Kleeberger; K H Buetow; R C Levitt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 6.  Interleukin-9 and T helper type 9 cells in rheumatic diseases.

Authors:  F Ciccia; G Guggino; A Ferrante; P Cipriani; R Giacomelli; G Triolo
Journal:  Clin Exp Immunol       Date:  2016-08       Impact factor: 4.330

7.  A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.

Authors:  J B Demoulin; C Uyttenhove; E Van Roost; B DeLestré; D Donckers; J Van Snick; J C Renauld
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

8.  Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.

Authors:  Jing Chen; Mike Petrus; Bonita R Bryant; Vinh Phuc Nguyen; Mindy Stamer; Carolyn K Goldman; Richard Bamford; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2008-03-13       Impact factor: 22.113

9.  Induction of Interleukin-9-Producing Mucosal Mast Cells Promotes Susceptibility to IgE-Mediated Experimental Food Allergy.

Authors:  Chun-Yu Chen; Jee-Boong Lee; Bo Liu; Shoichiro Ohta; Pin-Yi Wang; Andrey V Kartashov; Luke Mugge; J Pablo Abonia; Artem Barski; Kenji Izuhara; Marc E Rothenberg; Fred D Finkelman; Simon P Hogan; Yui-Hsi Wang
Journal:  Immunity       Date:  2015-09-22       Impact factor: 31.745

10.  Functional analysis of -351 interleukin-9 promoter polymorphism reveals an activator controlled by NF-kappaB.

Authors:  S B Early; P Huyett; K Brown-Steinke; L Borish; J W Steinke
Journal:  Genes Immun       Date:  2009-04-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.